FIELD: medicine.
SUBSTANCE: method involves administering required dose of renin-angiotensin inhibitor Ramipryl or its salt combined with a hypotensive drug, means for reducing cholesterol content, diuretic or aspirin to patients showing no signs of left ventricle dysfunction or cardiac insufficiency.
EFFECT: prevented cardiovascular attacks, angina pectoris, diabetes manifestations.
18 cl, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL PREPARATIONS AND THEIR USING FOR PROPHYLAXIS OF STROKE, DIABETES AND/OR CONGESTIVE CARDIAC INSUFFICIENCY | 2000 |
|
RU2272651C2 |
| PHARMACEUTICAL PREPARATIONS AND THEIR APPLICATION FOR PREVENTION OF STROKE, DIABETES AND/OR CONGESTIVE HEART FAILURE | 2005 |
|
RU2378018C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING HMG-CoA REDUCTASE INHIBITOR AND ACE INHIBITOR | 2016 |
|
RU2750934C2 |
| TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES | 2004 |
|
RU2380093C2 |
| CAPSULE AND DRUG PREPARATION FOR PREVENTING CARDIOVASCULAR DISEASES | 2009 |
|
RU2477123C2 |
| APPLICATION OF ORGANIC COMPOUNDS | 2005 |
|
RU2426532C2 |
| NEW MEDICINAL APPLICATION OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR (ACEI) IN TREATING DYSPEPTIC SYMPTOMS | 1996 |
|
RU2203092C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING CARDIOVASCULAR DISEASES | 2011 |
|
RU2491070C2 |
| APPLICATION OF SUBSTITUTED CYANOPYROLIDINES AND COMBINED PREPARATIONS CONTAINING THEM FOR TREATMENT OF LIPIDEMIA AND ASSOCIATED DISEASES | 2003 |
|
RU2362555C2 |
| NEBIVOLOL-INCLUDING COMPOSITIONS | 2005 |
|
RU2403037C2 |
